Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manoranjenni Chetty
Observed names:
M Chetty,
M. Chetty
Institutions:
Sanofi (United Kingdom),
University of KwaZulu-Natal
Observed institutions:
The University of Sydney,
University of the Witwatersrand,
Sanofi (United Kingdom),
Simcyp (United Kingdom),
Macquarie Hospital,
University of KwaZulu-Natal,
University of Wales
show all 7
ORCID:
0000-0001-8900-956X
Observed ORCID:
0000-0001-8900-956X
OpenAlex ID:
A5002054470
Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
2013
·
Miroslav Dostalek
, Iain Gardner
, et al.
·
Clinical Pharmacokinetics
·
250
Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics
2016
·
Katherine L. Gill
, Krishna K. Machavaram
, et al.
·
Clinical Pharmacokinetics
·
89
Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome
2009
·
M. Bebawy
, M. Chetty
·
Current Drug Metabolism
·
87
Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1‐Related Variability in Pharmacodynamics of Rosuvastatin
2014
·
RH Rose
, S Neuhoff
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
82
PDF
Physiologically based pharmacokinetic modelling to guide drug delivery in older people
2018
·
Manoranjenni Chetty
, Trevor N. Johnson
, et al.
·
Advanced Drug Delivery Reviews
·
73
PDF
CYP-Mediated Clozapine Interactions: How Predictable Are They?
2007
·
Manoranjenni Chetty
, Michael Murray
·
Current Drug Metabolism
·
66
Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability
2014
·
Manoranjenni Chetty
, Rachel H. Rose
, et al.
·
Frontiers in Pharmacology
·
62
PDF
Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz
2014
·
Panjasaram Naidoo
, Vasudevan V. Chetty
, et al.
·
European Journal of Clinical Pharmacology
·
52
Sex Differences in the Clearance of CYP3A4 Substrates: Exploring Possible Reasons for the Substrate Dependency and Lack of Consensus
2012
·
Manoranjenni Chetty
, Donald Mattison
, et al.
·
Current Drug Metabolism
·
44
A High-Throughput Assay Using Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous In Vivo Phenotyping of 5 Major Cytochrome P450 Enzymes in Patients
2009
·
Sussan Ghassabian
, Manoranjenni Chetty
, et al.
·
Therapeutic Drug Monitoring
·
44
Smoking and body weight influence the clearance of chlorpromazine
1994
·
M. Chetty
, R. Miller
, et al.
·
European Journal of Clinical Pharmacology
·
43
Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model
2015
·
Manoranjenni Chetty
, Linzhong Li
, et al.
·
Frontiers in Immunology
·
39
PDF
Therapeutic Monitoring of Valproate in Psychiatry: How Far Have We Progressed?
2006
·
Jessica Fleming
, Manoranjenni Chetty
·
Clinical Neuropharmacology
·
38
Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia
2008
·
Mary Bebawy
, Manoranjenni Chetty
·
BioEssays
·
37
Psychotropic Drug Interactions With Valproate
2005
·
Jessica Fleming
, Manoranjenni Chetty
·
Clinical Neuropharmacology
·
37
Phenytoin Auto-Induction
1998
·
Manoranjenni Chetty
, Raymond Miller
, et al.
·
Therapeutic Drug Monitoring
·
33
Design and conduct considerations for studies in patients with impaired renal function
2021
·
Paulien Ravenstijn
, Manoranjenni Chetty
, et al.
·
Clinical and Translational Science
·
29
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment
2019
·
M. De Sousa Mendes
, Manoranjenni Chetty
·
Drugs in R&D
·
29
PDF
Design and conduct considerations for studies in patients with hepatic impairment
2022
·
Paulien Ravenstijn
, Manoranjenni Chetty
, et al.
·
Clinical and Translational Science
·
28
Are Physiologically Based Pharmacokinetic Models Reporting the Right Cmax? Central Venous Versus Peripheral Sampling Site
2015
·
Helen Musther
, Katherine L. Gill
, et al.
·
The AAPS Journal
·
24
PDF
Physiologically-Based Pharmacokinetics
2011
·
Masoud Jamei
, Karen R. Yeo
, et al.
·
Springer eBooks
·
21
The use of a side effect as a qualitative indicator of plasma chlorpromazine levels
1999
·
M Chetty
, E Gouws
, et al.
·
European Neuropsychopharmacology
·
20
Important Metabolites to Measure in Pharmacodynamic Studies of Chlorpromazine
1994
·
M. Chetty
, S. V. Moodley
, et al.
·
Therapeutic Drug Monitoring
·
19
Dosing and Therapeutic Monitoring of Phenytoin in Young Adults After Neurotrauma: Are Current Practices Relevant?
2007
·
Vivien Frend
, Manoranjenni Chetty
·
Clinical Neuropharmacology
·
18
Clopidogrel Dosing: Current Successes and Emerging Factors for Further Consideration
2020
·
Manoranjenni Chetty
, Paulien Ravenstijn
, et al.
·
Clinical Pharmacology & Therapeutics
·
16
Show more works
View as search
Works count:
50
Citation count:
1,416
H-index:
21
I10-index:
32
Year
Topic
Type